Titan Pharmaceuticals Stock Performance
| TTNP Stock | USD 7.10 0.16 2.20% |
On a scale of 0 to 100, Titan Pharmaceuticals holds a performance score of 4. The entity has a beta of -0.7, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Titan Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Titan Pharmaceuticals is likely to outperform the market. Please check Titan Pharmaceuticals' sortino ratio, semi variance, as well as the relationship between the Semi Variance and day median price , to make a quick decision on whether Titan Pharmaceuticals' existing price patterns will revert.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Titan Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain basic indicators, Titan Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
Five Day Return (2.20) | Year To Date Return (13.94) | Ten Year Return (99.94) | All Time Return (99.99) |
Last Split Factor 1:20 | Dividend Date 2020-12-01 | Last Split Date 2024-01-09 |
1 | Is Titan Pharmaceuticals, Inc. common stock Stock a Good Value - InvestorsObserver | 01/22/2024 |
2 | Titan Pharmaceuticals Regains Compliance with Nasdaq Listing - TipRanks.com - TipRanks | 01/26/2024 |
3 | StockNews.com Begins Coverage on Titan Pharmaceuticals | 02/15/2024 |
4 | Titan Pharmaceuticals Coverage Initiated at StockNews.com | 02/29/2024 |
5 | Acquisition by Greenberg Eric Howard of 25000 shares of Titan Pharmaceuticals at 1.52 subject to Rule 16b-3 | 03/06/2024 |
6 | When the Price of Talks, People Listen - Stock Traders Daily.com | 03/07/2024 |
7 | Disposition of tradable shares by Choong Choon Hau of Titan Pharmaceuticals at 9.32 subject to Rule 16b-3 | 03/18/2024 |
8 | Acquisition by Joseph Akers of 25000 shares of Titan Pharmaceuticals at 4.02 subject to Rule 16b-3 | 03/26/2024 |
9 | Disposition of tradable shares by Flores Francisco of Titan Pharmaceuticals subject to Rule 16b-3 | 04/02/2024 |
10 | Titan Pharmaceuticals Overhauls Leadership, Settles with Ex-Directors - TipRanks.com - TipRanks | 04/03/2024 |
| Begin Period Cash Flow | 3.1 M | |
| Free Cash Flow | -7.1 M |
Titan |
Titan Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 655.00 in Titan Pharmaceuticals on January 20, 2024 and sell it today you would earn a total of 55.00 from holding Titan Pharmaceuticals or generate 8.4% return on investment over 90 days. Titan Pharmaceuticals is currently generating 0.3385% in daily expected returns and assumes 6.4561% risk (volatility on return distribution) over the 90 days horizon. In different words, 57% of stocks are less volatile than Titan, and 94% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Titan Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Titan Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Titan Pharmaceuticals, and traders can use it to determine the average amount a Titan Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0524
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TTNP | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.46 actual daily | 57 57% of assets are less volatile |
Expected Return
| 0.34 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Titan Pharmaceuticals is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Titan Pharmaceuticals by adding it to a well-diversified portfolio.
Titan Pharmaceuticals Fundamentals Growth
Titan Stock prices reflect investors' perceptions of the future prospects and financial health of Titan Pharmaceuticals, and Titan Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Titan Stock performance.
| Return On Equity | -1.39 | ||||
| Return On Asset | -0.75 | ||||
| Operating Margin | (39.55) % | ||||
| Current Valuation | 297.06 K | ||||
| Shares Outstanding | 914.23 K | ||||
| Price To Earning | (3.60) X | ||||
| Price To Book | 1.00 X | ||||
| Price To Sales | 36.07 X | ||||
| Revenue | 184 K | ||||
| Gross Profit | (4.37 M) | ||||
| EBITDA | (7.17 M) | ||||
| Net Income | (5.57 M) | ||||
| Cash And Equivalents | 6.42 M | ||||
| Cash Per Share | 0.44 X | ||||
| Total Debt | 565 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 3.06 X | ||||
| Book Value Per Share | 8.50 X | ||||
| Cash Flow From Operations | (7.09 M) | ||||
| Earnings Per Share | (7.41) X | ||||
| Market Capitalization | 6.49 M | ||||
| Total Asset | 8.09 M | ||||
| Retained Earnings | (391.83 M) | ||||
| Working Capital | 6.57 M | ||||
| Current Asset | 12.24 M | ||||
| Current Liabilities | 4.85 M | ||||
About Titan Pharmaceuticals Performance
To evaluate Titan Pharmaceuticals Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Titan Pharmaceuticals generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Titan Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Titan Pharmaceuticals market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Titan's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 227.01 | 215.66 | |
| Return On Tangible Assets | (0.69) | (0.72) | |
| Return On Capital Employed | (1.10) | (1.15) | |
| Return On Assets | (0.69) | (0.72) | |
| Return On Equity | (0.84) | (0.88) |
Things to note about Titan Pharmaceuticals performance evaluation
Checking the ongoing alerts about Titan Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Titan Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Titan Pharmaceuticals had very high historical volatility over the last 90 days | |
| Titan Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 184 K. Net Loss for the year was (5.57 M) with loss before overhead, payroll, taxes, and interest of (4.37 M). | |
| Titan Pharmaceuticals currently holds about 6.42 M in cash with (7.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44. | |
| Titan Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Roughly 45.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Titan Pharmaceuticals Overhauls Leadership, Settles with Ex-Directors - TipRanks.com - TipRanks |
- Analyzing Titan Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Titan Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Titan Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Titan Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Titan Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Titan Pharmaceuticals' stock. These opinions can provide insight into Titan Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Titan Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Titan Stock analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is Titan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Titan Pharmaceuticals. If investors know Titan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Titan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.41) | Revenue Per Share 0.245 | Quarterly Revenue Growth (1.00) | Return On Assets (0.75) | Return On Equity (1.39) |
The market value of Titan Pharmaceuticals is measured differently than its book value, which is the value of Titan that is recorded on the company's balance sheet. Investors also form their own opinion of Titan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Titan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Titan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Titan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Titan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Titan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Titan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.